Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients

J Y Lee1, M A Chiong, S C Estrada

  • 1Metabolic Services, Genetic Health Services Victoria, Royal Children's Hospital, Melbourne, Australia.

Insights

Maple syrup urine disease (MSUD) is a rare metabolic disorder. Early diagnosis and improved management in the Philippines show trends toward reduced mortality, but late referrals still impact outcomes.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Maple syrup urine disease (MSUD) is a rare inherited disorder of branched-chain amino acid metabolism.
  • It is the most common inborn error of metabolism in the Philippines.
  • Despite advances, clinical outcomes for MSUD patients remain poor due to late diagnosis and management.

Purpose of the Study:

  • To review the diagnosis and management of 21 MSUD patients in the Philippines between 1999 and 2004.
  • To compare these findings with a previous series to assess improvements in diagnosis and care.
  • To identify factors contributing to poor clinical outcomes and recommend improvements.

Main Methods:

  • Retrospective review of 21 MSUD patients diagnosed between 1999 and 2004.
  • Clinical presentation, diagnosis methods (clinical suspicion, urine/blood tests), and acute management (peritoneal dialysis) were analyzed.
  • Comparison with a historical cohort of 26 patients diagnosed since 1992.

Main Results:

  • Patients presented between 2-14 days of life, diagnosed by a mean of 39 days.
  • Classical 'burnt sugar' odor noted in 81% of patients.
  • Mortality rate was 24%, with a trend towards earlier diagnosis and reduced mortality in the later series.

Conclusions:

  • While diagnosis and management capabilities exist in the Philippines, late referrals and inadequate long-term care hinder optimal outcomes.
  • Early detection through newborn screening for suggestive symptoms (sepsis, feeding difficulties) is crucial.
  • Prompt biochemical analysis (urine ketones, blood leucine/isoleucine) is recommended for suspected cases.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...